Prothena Corporation plc

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012
Assets
Cash & Equivalents $417.6M $386.9M $370.6M $293.6M $176.7M $124.9M
Accounts Receivable $240.0K $178.0K $509.0K $1.7M $0 —
Inventory — — — — — —
Total Current Assets $426.3M $391.4M $377.4M $299.1M $178.2M $125.8M
Property, Plant & Equipment $55.0M $56.5M $3.9M $3.1M $3.4M $3.4M
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — —
Total Assets $496.3M $460.0M $385.2M $304.1M $182.4M $129.3M
Liabilities
Accounts Payable $13.6M $13.1M $4.5M $4.7M $1.8M $0
Total Current Liabilities $37.4M $41.1M $22.2M $12.0M $7.4M $1.7M
Long-Term Debt — — — — — —
Total Liabilities $89.1M $94.6M $24.6M $14.2M $9.1M $2.8M
Stockholders' Equity
Retained Earnings $-442.4M $-289.2M $-129.1M $-48.5M $-41.3M $-345.0K
Total Stockholders' Equity $407.2M $365.4M $360.7M $289.9M $173.3M $126.5M
← Newer Page 2 of 2 Older →